Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 2
1957 1
1958 1
1962 1
1966 1
1969 1
1970 1
1971 1
1972 1
1974 1
1975 2
1976 2
1978 1
1980 1
1982 1
1983 1
1984 1
1985 1
1986 1
1987 1
1988 1
1989 1
2012 2
2015 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 3
2022 5
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary Rehabilitation for Patients After COPD Exacerbation.
Shibuya M, Yamamoto S, Kobayashi S, Nishie K, Yamaga T, Kawachi S, Matsunaga A. Shibuya M, et al. Among authors: nishie k. Respir Care. 2022 Mar;67(3):360-369. doi: 10.4187/respcare.09066. Epub 2021 Dec 7. Respir Care. 2022. PMID: 34876493 Free article. Review.
Update on the treatment of cancer cachexia.
Nishie K, Nishie T, Sato S, Hanaoka M. Nishie K, et al. Drug Discov Today. 2023 Sep;28(9):103689. doi: 10.1016/j.drudis.2023.103689. Epub 2023 Jun 28. Drug Discov Today. 2023. PMID: 37385369 Review.
Anamorelin for cancer cachexia.
Nishie K, Sato S, Hanaoka M. Nishie K, et al. Drugs Today (Barc). 2022 Mar;58(3):97-104. doi: 10.1358/dot.2022.58.3.3381585. Drugs Today (Barc). 2022. PMID: 35274629 Review.
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study).
Araki T, Kanda S, Komatsu M, Sonehara K, Tateishi K, Takada M, Kato A, Yamamoto M, Nishie K, Hama M, Agatsuma T, Kakizaki Y, Yoshiike F, Matsuo A, Chiaki T, Samizo K, Takagi Y, Yamaura M, Hanaoka M, Koizumi T. Araki T, et al. Among authors: nishie k. Transl Lung Cancer Res. 2023 Jun 30;12(6):1320-1327. doi: 10.21037/tlcr-23-12. Epub 2023 Jun 15. Transl Lung Cancer Res. 2023. PMID: 37425417 Free PMC article.
Pharmacology of solanine.
Nishie K, Gumbmann MR, Keyl AC. Nishie K, et al. Toxicol Appl Pharmacol. 1971 May;19(1):81-92. doi: 10.1016/0041-008x(71)90192-x. Toxicol Appl Pharmacol. 1971. PMID: 4105761 No abstract available.
Toxicity of methylimidazoles.
Nishie K, Waiss AC Jr, Keyl AC. Nishie K, et al. Toxicol Appl Pharmacol. 1969 Mar;14(2):301-7. doi: 10.1016/0041-008x(69)90111-2. Toxicol Appl Pharmacol. 1969. PMID: 5772854 No abstract available.
48 results